PEG — Pharma Equity A/S Balance Sheet
0.000.00%
- DKK122.75m
- DKK137.53m
Annual balance sheet for Pharma Equity A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0 | 0 | 0.182 | 4.23 | 4.23 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.082 | 0.137 | 0.14 | 62.6 | 60.3 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.082 | 0.145 | 71.1 | 67.2 | 65.3 |
| Net Property, Plant And Equipment | — | — | — | 0.507 | 0.271 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 57.6 | 63.6 | 71.1 | 67.7 | 65.6 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23.3 | 14.5 | 25 | 34.3 | 8.63 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 23.3 | 21.1 | 25 | 42.4 | 16.7 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 34.3 | 42.6 | 46 | 25.3 | 48.9 |
| Total Liabilities & Shareholders' Equity | 57.6 | 63.6 | 71.1 | 67.7 | 65.6 |
| Total Common Shares Outstanding |